{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:02:55Z","timestamp":1756425775905,"version":"3.44.0"},"reference-count":12,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2016,7,3]]},"abstract":"<jats:p>Choroidal neovascularisation (CNV) is a major cause of visual loss and treatment options aim to halt progression and stabilise vision. We describe a 29-year-old woman who presented with blurred vision and distortion in her left eye while 26\u2005weeks pregnant. She was diagnosed with idiopathic CNV and multiple treatment options were discussed. The patient did not want to undertake any risks from having an anti vascular endothelial growth factor agent during pregnancy. Therefore on discussion with the obstetric team, she elected to have early delivery at 32\u2005weeks followed by a course of intravitreal bevacizumab. Subsequently there was resolution of symptoms and intraretinal and subretinal fluid. CNV is uncommonly seen in pregnancy and there remains no consensus on treatment. We describe the third reported case of idiopathic CNV in pregnancy. Careful patient counselling and close liaison between the ophthalmology and obstetric teams are necessary in this condition to obtain a safe outcome while maximising vision.<\/jats:p>","DOI":"10.1136\/bcr-2016-215787","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T10:57:54Z","timestamp":1468925874000},"page":"bcr2016215787","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Idiopathic choroidal neovascularisation in pregnancy: treatment options and a successful outcome"],"prefix":"10.1136","volume":"2016","author":[{"given":"Samantha Roshani","family":"De Silva","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Stoke Mandeville Hospital, Aylesbury, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhat","family":"Bibi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Stoke Mandeville Hospital, Aylesbury, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan","family":"Sim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Stoke Mandeville Hospital, Aylesbury, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandeep Singh","family":"Bindra","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Stoke Mandeville Hospital, Aylesbury, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,7,19]]},"reference":[{"doi-asserted-by":"publisher","key":"2025082800195315000_2016.jul19_1.bcr2016215787.1","DOI":"10.1016\/j.survophthal.2012.08.001"},{"doi-asserted-by":"publisher","key":"2025082800195315000_2016.jul19_1.bcr2016215787.2","DOI":"10.1016\/S0161-6420(95)30968-2"},{"doi-asserted-by":"publisher","key":"2025082800195315000_2016.jul19_1.bcr2016215787.3","DOI":"10.1016\/S0161-6420(98)91021-1"},{"key":"2025082800195315000_2016.jul19_1.bcr2016215787.4","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/eye.2008.218","article-title":"Exposure to verteporfin and bevacizumab therapy for choroidal neovascularization secondary to punctate inner choroidopathy during pregnancy","volume":"23","author":"Rosen","year":"2009","journal-title":"Eye (Lond)"},{"doi-asserted-by":"publisher","key":"2025082800195315000_2016.jul19_1.bcr2016215787.5","DOI":"10.1038\/eye.2013.311"},{"key":"2025082800195315000_2016.jul19_1.bcr2016215787.6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.47102\/annals-acadmedsg.V39N2p143","article-title":"Inadvertent use of bevacizumab to treat choroidal neovascularisation during pregnancy: a case report","volume":"39","author":"Wu","year":"2010","journal-title":"Ann Acad Med Singap"},{"key":"2025082800195315000_2016.jul19_1.bcr2016215787.7","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1111\/j.1755-3768.2009.01572.x","article-title":"Early loss of pregnancy after intravitreal bevacizumab injection","volume":"88","author":"Petrou","year":"2010","journal-title":"Acta Ophthalmol"},{"doi-asserted-by":"publisher","key":"2025082800195315000_2016.jul19_1.bcr2016215787.8","DOI":"10.1038\/eye.2008.93"},{"doi-asserted-by":"publisher","key":"2025082800195315000_2016.jul19_1.bcr2016215787.9","DOI":"10.1159\/000328385"},{"doi-asserted-by":"publisher","key":"2025082800195315000_2016.jul19_1.bcr2016215787.10","DOI":"10.1097\/00006982-199911000-00007"},{"key":"2025082800195315000_2016.jul19_1.bcr2016215787.11","first-page":"3158","article-title":"VEGF is major stimulator in model of choroidal neovascularization","volume":"41","author":"Kwak","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"doi-asserted-by":"publisher","key":"2025082800195315000_2016.jul19_1.bcr2016215787.12","DOI":"10.1042\/cs0920567"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2016-215787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:20:04Z","timestamp":1756365604000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2016-215787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,19]]},"references-count":12,"alternative-id":["10.1136\/bcr-2016-215787"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2016-215787","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2016,7,19]]}}}